Gemcitabine

Product NDC
0409-0186
11-digit product format
004090186
Labeler code
0409
Product ID
0409-0186_111b13bb-6793-4b33-b845-0dc9b46837de
Type
HUMAN PRESCRIPTION DRUG
Nonproprietary name
GEMCITABINE
Dosage form
INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION
Route
INTRAVENOUS
Labeler
Hospira, Inc.
Application
ANDA078339
Marketing category
ANDA
Marketing start
2011-07-26
Substance
GEMCITABINE HYDROCHLORIDE
Active strength
38 mg/mL
Pharmacologic classes
Nucleic Acid Synthesis Inhibitors [MoA], Nucleoside Metabolic Inhibitor [EPC]
NDC exclude flag
No
Listing certified through
2026-12-31
Current FDA listing
Yes

Additional Listing Data#

Finished product
Yes
Brand name base
Gemcitabine
Listing expiration
2026-12-31

Active Ingredients#

Ingredient, Strength table
IngredientStrength
GEMCITABINE HYDROCHLORIDE38 mg/mL

Harmonized Identifiers#

Field, Values table
FieldValues
UniiU347PV74IL
Rxcui1719000, 1719003

DailyMed Product Concepts#

Product concept, Relation, Version table
Product conceptRelationVersionEffective
6bd95106-a412-1dad-b9cc-4cb74bfb27ceProduct name220230315
a2b7d477-0e35-4772-8a9d-99c71e3e210bProduct name220190614
4c31c9b8-06d5-4f83-9eb7-cd946af7067aProduct name520190612
a12a1c0c-65f2-45a0-8bf0-7dfc55c750b6Product name120180829
d2980057-8cff-4896-979e-b4c394974cfdProduct name120170829
d5e51f11-ad28-caa4-4b49-4143974782adProduct name120150831
290f523a-f9db-9774-b5a9-e1f908ac1782Product name120150828
0ca1d589-929b-4b33-bc5b-1d84abdafa6aProduct name120150324
fc363c46-397b-4476-ac0f-70e43e8e4592Product name120150324
c6b65c52-69c7-df49-550a-a50c137f6218Product name120140508

DailyMed Package Descriptions#

Package NDC, Product, Description table
Package NDCProductDescriptionFormQuantityStrengthSPL version
0409-0186-01Gemcitabine25 mL in 1 VIAL, SINGLE-DOSEINJECTION, POWDER, LYOPHILIZED,2527
0409-0186-01Gemcitabine1 in 1 CARTONINJECTION, POWDER, LYOPHILIZED,127

DailyMed Dashboard NDC Coverage#

NDC, Dashboard title, SPL version table
NDCDashboard titleSPL versionValidationDashboard ZIP
0409-0186GEMCITABINE INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION [HOSPIRA, INC.]27Current NDC, Legacy NDC, 2 package rows20240903_d16907e7-a8c8-4039-ace4-cf4e24ba68c0.zip

DailyMed RxNorm Mappings#

RxCUI, RxNorm string, TTY table
RxCUIRxNorm stringTTYDailyMedSPL version
1719003gemcitabine 1 GM InjectionPSNd16907e7-a8c8-4039-ace4-cf4e24ba68c027
1719000gemcitabine 200 MG InjectionPSNd16907e7-a8c8-4039-ace4-cf4e24ba68c027
1719003gemcitabine 1000 MG InjectionSCDd16907e7-a8c8-4039-ace4-cf4e24ba68c027
1719000gemcitabine 200 MG InjectionSCDd16907e7-a8c8-4039-ace4-cf4e24ba68c027
1719003gemcitabine (as gemcitamine HCl) 1 GM InjectionSYd16907e7-a8c8-4039-ace4-cf4e24ba68c027
1719000gemcitabine (as gemcitamine HCl) 200 MG InjectionSYd16907e7-a8c8-4039-ace4-cf4e24ba68c027
1719003gemcitabine 1 GM InjectionSYd16907e7-a8c8-4039-ace4-cf4e24ba68c027

Packages#

Package NDC, 11-digit format, Description table
Package NDC11-digit formatDescriptionMarketing startMarketing endSampleExclude flagStatus
0409-0186-01004090186011 VIAL, SINGLE-DOSE in 1 CARTON (0409-0186-01) / 25 mL in 1 VIAL, SINGLE-DOSE2011-07-260000-00-00NoNoCurrent